Skip To Main Content
Ying Jie Chee on Muck Rack

Ying Jie Chee

As seen in: Wiley Online Library, MDPI, Diabetes Research and Clinical Practice
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ying Jie

Contact Ying Jie, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

First-Line Dapagliflozin, Metformin, or Combination Therapy in Type 2 Diabetes: Vascular and Molecular Outcomes of a Randomised Controlled Trial

|
By Ying Jie Chee, Sanchalika Acharyya, Huiling Liew
| Wiley Online Library Verified
1 Introduction Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of mortality in type 2 diabetes mellitus (T2DM), conferring two to four times increased cardiovascular risk [1]. Despite advancements in glucose-lowering therapies, substantial residual ASCVD risk persists, with landmark trials (ACCORD [2], ADVANCE [3] and VADT [4]) demonstrating limited efficacy of intensive glucose control in eliminating excess ASCVD risk in type 2 diabetes.
Open in Who Shared Issue with article?

Barriers and facilitators of physical activity and exercise among adults with type 2 diabetes mellitus in Singapore

|
By Ying Jie Chee, Huiling Liew, Sanchalika Acharyya, Rinkoo Dalan
| Wiley Online Library Verified
DATA AVAILABILITY STATEMENT Data are available upon reasonable request and queries regarding data availability will be referred to the corresponding author.
Open in Who Shared View Duplicates (220) Issue with article?

The Interplay Between Immunity, Inflammation and Endothelial Dysfunction

|
By Ying Jie Chee, Rinkoo Dalan, Christine Cheung, Ying Jie
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?
See all 9 articles